SCHEMBL8695578

SCHEMBL8695578

O=C(Cl)N1CCN(c2ccc3ccccc3c2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.65
▸ HTR3A P46098 2/20 0.58
▸ HCAR2 Q8TDS4 1/20 0.56
▸ LMNA P02545 2/20 0.56
▸ TSHR P16473 1/20 0.56
▸ MAPT P10636 3/20 0.56
▸ GAA P10253 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ USP2 O75604 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ SIGMAR1 Q99720 2/20 0.54
▸ HTR3E A5X5Y0 1/20 0.54
▸ HTR3B O95264 1/20 0.54
▸ HTR5A P47898 1/20 0.54
▸ HTR3D Q70Z44 1/20 0.54
▸ HTR3C Q8WXA8 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20274197 0.81 AKR1C3 (0.62) AKR1C3HTR3AHCAR2LMNATSHR
SCHEMBL426469 0.79 ALDH1A1 (0.65) AKR1C3LMNATSHRMAPTALDH1A1
SCHEMBL12806786 0.77 HTR3A (0.72) AKR1C3HTR3AHCAR2LMNATSHR
SCHEMBL5537738 0.77 HTR1A (0.73) AKR1C3ALDH1A1KMT2ARAB9AMEN1
SCHEMBL5543934 0.77 MAPT (0.68) LMNATSHRMAPTGAAALDH1A1
SCHEMBL1423108 0.75 MAPT (0.64) LMNATSHRMAPTGAAALDH1A1
SCHEMBL13780705 0.75 SIGMAR1 (0.58) AKR1C3HTR3AHCAR2LMNATSHR
SCHEMBL3534699 0.75 HTR3A (0.69) AKR1C3HTR3AHCAR2LMNATSHR
SCHEMBL29594813 0.75 HTR3A (0.69) AKR1C3HTR3AHCAR2LMNATSHR
SCHEMBL19059406 0.74 TDP1 (0.62) LMNAMAPTGAAALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5789412-A 5-HYDROXYTRYPTAMINE (SEROTONIN) RECEPTOR ANTAGONISTS FOR THE CURATIVE OR PREVENTIVE TREATMENT OF PAIN, DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS, ANXIETY OR PANIC ATTACK, OR CANCER PIERRE FABRE MEDICAMENT (FR) 1998-08-04 — — US disclosed
EP-0773937-A1 NOVEL ARYL PIPERAZINE-DERIVED PIPERAZIDE DERIVATIVES, METHODS FOR THEIR PREPARATION, THEIR USE AS DRUGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME PIERRE FABRE MEDICAMENT (FR) 1997-05-21 — — EP disclosed
WO-1996002525-A1 NOVEL ARYL PIPERAZINE-DERIVED PIPERAZIDE DERIVATIVES, METHODS FOR THEIR PREPARATION, THEIR USE AS DRUGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME PIERRE FABRE MEDICAMENT (FR) 1996-02-01 — — WO disclosed
Send feedback